Quarterly report · Q2
3645.TEDINET S100SMIQ
Period2023-06-01 → 2023-11-30
Filed2024-01-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥4.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Operating income | ¥170m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥178m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥194m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥432m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥205m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥192m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥207m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥116m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥116m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥116m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥126m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥130m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥3.6bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥3.5bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥3.4bn | at 2022-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥131m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥429m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥59m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥62m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥32m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥18m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥906,000 | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥12.8 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.39 | 2023-09-01 → 2023-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.97 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.09 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.36 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 56.4% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.8% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥315m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥7m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥68m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥390m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-11-30 | ¥392m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥2,000 |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥297m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥12,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥25m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥213,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥51m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥374m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥376m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 880260 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.0973 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 783460 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0866 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 594760 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0657 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 259700 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0287 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 179900 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0198 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 115820 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0128 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 107800 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0119 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 100000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0110 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 93720 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0103 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 83920 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0092 | |
| Number of shares held | CurrentQuarterInstant | 3199340 | |
| Shareholding ratio | CurrentQuarterInstant | 0.3537 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 1727700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 9038400 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 90384 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 6900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 10773000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 90384 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 1727700 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 1727700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1604 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 1727700 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 1727700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.1604 | |
| Cash and deposits | Prior1YearInstant | 1518550000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 1399526000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 693749000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 823518000 | JPY |
| Merchandise | Prior1YearInstant | 123968000 | JPY |
| Merchandise | CurrentQuarterInstant | 223467000 | JPY |
| Advance payments trade | Prior1YearInstant | 57666000 | JPY |
| Advance payments trade | CurrentQuarterInstant | 55765000 | JPY |
| Other ca | Prior1YearInstant | 84900000 | JPY |
| Other ca | CurrentQuarterInstant | 98015000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |